NCT07839819
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07839819
Title Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PharmaMar
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | DEU

Facility Status City State Zip Country Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Institut Bergonie Bordeaux France Details
Centre Leon Berard - Lyon Lyon France Details
Centre Antoine Lacassagne Nice France Details
Helios Klinikum Berlin-Buch Buckow Germany Details
Universitaetsmedizin Mainz Mainz Germany Details
START Lisbon - ULS Santa Maria Lisbon Portugal Details
Instituto Portugues De Oncologia Do Porto Francisco Gentil Epe Ipo Porto Ipopfg Clinica De Onco Hematologia Porto Portugal Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field